Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial

B Escudier; A Pluzanska; P Koralewski; A Ravaud; S Bracarda; C Szczylik; C Chevreau; M Filipek; B Melichar; E Bajetta; V Gorbunova; J-O Bay; I Bodrogi; A Jagiello-Gruszfeld; N Moore; Pirkko-Liisa Kellokumpu-Lehtinen

Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial

B Escudier
, A Pluzanska
, P Koralewski
, A Ravaud
, S Bracarda
, C Szczylik
, C Chevreau
, M Filipek
, B Melichar
, E Bajetta
, V Gorbunova
, J-O Bay
, I Bodrogi
, A Jagiello-Gruszfeld
, N Moore
, Pirkko-Liisa Kellokumpu-Lehtinen

Research output: Contribution to journal › Article › Scientific › peer-review

2132 Citations (Scopus)

Original language	English
Pages (from-to)	2103-2111
Journal	The Lancet
Volume	370
Issue number	22/29
Publication status	Published - 2007
Publication type	A1 Journal article-refereed

Cite this

Escudier, B., Pluzanska, A., Koralewski, P., Ravaud, A., Bracarda, S., Szczylik, C., Chevreau, C., Filipek, M., Melichar, B., Bajetta, E., Gorbunova, V., Bay, J.-O., Bodrogi, I., Jagiello-Gruszfeld, A., Moore, N., & Kellokumpu-Lehtinen, P.-L. (2007). Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial. The Lancet, 370(22/29), 2103-2111.

@article{4dd60dbc70b04e8095f0bed587d132c8,

title = "Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial",

author = "B Escudier and A Pluzanska and P Koralewski and A Ravaud and S Bracarda and C Szczylik and C Chevreau and M Filipek and B Melichar and E Bajetta and V Gorbunova and J-O Bay and I Bodrogi and A Jagiello-Gruszfeld and N Moore and Pirkko-Liisa Kellokumpu-Lehtinen",

year = "2007",

language = "English",

volume = "370",

pages = "2103--2111",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier",

number = "22/29",

}

Escudier, B, Pluzanska, A, Koralewski, P, Ravaud, A, Bracarda, S, Szczylik, C, Chevreau, C, Filipek, M, Melichar, B, Bajetta, E, Gorbunova, V, Bay, J-O, Bodrogi, I, Jagiello-Gruszfeld, A, Moore, N & Kellokumpu-Lehtinen, P-L 2007, 'Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial', The Lancet, vol. 370, no. 22/29, pp. 2103-2111.

TY - JOUR

T1 - Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial

AU - Escudier, B

AU - Pluzanska, A

AU - Koralewski, P

AU - Ravaud, A

AU - Bracarda, S

AU - Szczylik, C

AU - Chevreau, C

AU - Filipek, M

AU - Melichar, B

AU - Bajetta, E

AU - Gorbunova, V

AU - Bay, J-O

AU - Bodrogi, I

AU - Jagiello-Gruszfeld, A

AU - Moore, N

AU - Kellokumpu-Lehtinen, Pirkko-Liisa

PY - 2007

Y1 - 2007

M3 - Article

SN - 0140-6736

VL - 370

SP - 2103

EP - 2111

JO - The Lancet

JF - The Lancet

IS - 22/29

ER -